Business Description
Arterra Bioscience SpA
ISIN : IT0005386369
Share Class Description:
MIL:ABS: Ordinary SharesCompare
Compare
Traded in other countries / regions
ABS.Italy IPO Date
2019-10-28Description
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.65 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.35 | |||||
| Interest Coverage | 105.9 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.63 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.9 | |||||
| 3-Year EBITDA Growth Rate | 22.5 | |||||
| 3-Year EPS without NRI Growth Rate | 13 | |||||
| 3-Year FCF Growth Rate | 113.6 | |||||
| 3-Year Book Growth Rate | 13.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.1 | |||||
| 9-Day RSI | 41.34 | |||||
| 14-Day RSI | 43.38 | |||||
| 6-1 Month Momentum % | 19.76 | |||||
| 12-1 Month Momentum % | -20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.69 | |||||
| Quick Ratio | 5.51 | |||||
| Cash Ratio | 3.22 | |||||
| Days Inventory | 238.53 | |||||
| Days Sales Outstanding | 41.58 | |||||
| Days Payable | 45.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.35 | |||||
| Dividend Payout Ratio | 0.59 | |||||
| Forward Dividend Yield % | 5.35 | |||||
| 5-Year Yield-on-Cost % | 5.35 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 6.17 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.66 | |||||
| Operating Margin % | 21.39 | |||||
| Net Margin % | 21.75 | |||||
| ROE % | 10.33 | |||||
| ROA % | 8.62 | |||||
| ROIC % | 13.31 | |||||
| ROC (Joel Greenblatt) % | 44.25 | |||||
| ROCE % | 11.58 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.47 | |||||
| PE Ratio without NRI | 11.06 | |||||
| Price-to-Owner-Earnings | 10.65 | |||||
| PEG Ratio | 0.68 | |||||
| PS Ratio | 2.49 | |||||
| PB Ratio | 1.14 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| Price-to-Operating-Cash-Flow | 8.96 | |||||
| EV-to-EBIT | 6.97 | |||||
| EV-to-EBITDA | 4.96 | |||||
| EV-to-Revenue | 1.85 | |||||
| EV-to-FCF | 6.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.61 | |||||
| Price-to-Graham-Number | 0.75 | |||||
| Price-to-Net-Current-Asset-Value | 2.08 | |||||
| Price-to-Net-Cash | 6.45 | |||||
| Earnings Yield (Greenblatt) % | 14.35 | |||||
| Forward Rate of Return (Yacktman) % | 20.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arterra Bioscience SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.951 | ||
| EPS (TTM) (€) | 0.164 | ||
| Beta | 0.89 | ||
| Volatility % | 31.2 | ||
| 14-Day RSI | 43.38 | ||
| 14-Day ATR (€) | 0.045226 | ||
| 20-Day SMA (€) | 1.9485 | ||
| 12-1 Month Momentum % | -20 | ||
| 52-Week Range (€) | 1.48 - 2.5 | ||
| Shares Outstanding (Mil) | 6.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arterra Bioscience SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arterra Bioscience SpA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arterra Bioscience SpA Frequently Asked Questions
What is Arterra Bioscience SpA(MIL:ABS)'s stock price today?
The current price of MIL:ABS is €1.87. The 52 week high of MIL:ABS is €2.50 and 52 week low is €1.48.
When is next earnings date of Arterra Bioscience SpA(MIL:ABS)?
The next earnings date of Arterra Bioscience SpA(MIL:ABS) is .
Does Arterra Bioscience SpA(MIL:ABS) pay dividends? If so, how much?
The Dividend Yield %  of Arterra Bioscience SpA(MIL:ABS) is 5.35% (As of Today), Highest Dividend Payout Ratio of Arterra Bioscience SpA(MIL:ABS) was 0.59. The lowest was 0.27. And the median was 0.27. The  Forward Dividend Yield % of Arterra Bioscience SpA(MIL:ABS) is 5.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers